✦ LIBER ✦

Infrequent mutations and no methylation of CDKN2A (p16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan

✍ Scribed by Y.-W Lin; C.-H Chen; G.-T Huang; P.-H Lee; J.-T Wang; D.-S Chen; F.-J Lu; J.-C Sheu

Book ID: 117665897
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 262 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)00189-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p16 (cdkN2/MTS1/INK4A) expression in spo

p16 (cdkN2/MTS1/INK4A) expression in sporadic colorectal carcinomas

✍ L.M Rodriguez; R.B Penetrante; N.J Nowak; M Rodriguez-Bigas; D.L Driscoll; E Hoo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 163 KB

No p16INK4A/CDKN2/MTS1 mutations indepen

No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas

✍ Meye, Axel; Würl, Peter; Hinze, Raoul; Berger, Dieter; Bache, Matthias; Schmidt, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

The p16 INK4A /CDKN2/MTS1 gene encodes a specific inhibitor of cyclin-dependent kinases (CDKs) 4 and 6. This study investigates p16 INK4A gene status and expression in mesenchymal tumours, in particular soft tissue sarcomas (STSs). Employing non-radioactive polymerase chain reaction-single strand co

Deletional, mutational, and methylation

Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer

✍ David F. Jarrard; G. Steven Bova; Charles M. Ewing; Sokhom S. Pin; Son H. Nguyen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

The tumor suppressor gene CDKN2 (p16/MTS1) resides on chromosome 9p21 and encodes a 16 kDa inhibitor of the cyclin-dependent kinases. Inactivation of CDKN2 by homozygous deletion, point mutation, and recently described aberrant methylation in the 5' promoter region may increase progression through t

Loss of heterozygosity on chromosome 9 a

Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers

✍ Françoise Muzeau; Jean François Fléjou; Gilles Thomas; Richard Hamelin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

Loss of heterozygosity on chromosome 9 has been reported in a variety of human cancers. The cyclin-dependent kinase inhibitor p16 gene, mapped on chromosome 9p21, is presumed to be the tumor-suppressor gene localized in this chromosome. The aim of our study was to determine, in 26 Barrett's adenocar

Methylation of the multi tumor suppresso

Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia

✍ Iravani, M; Dhat, R; Price, C M 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 367 KB

Frequency of mutation and deletion of th

Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population

✍ K Biden; J Young; R Buttenshaw; J Searle; G Cooksley; D B Xu; B Leggett 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

The tumor suppressor gene CDKN2A (MTS1/p16), located on chromosome 9p21, is inactivated in a variety of tumors including melanomas and tumors of the biliary tract, pancreas, and stomach. The aim of the present study was to determine whether this gene is inactivated in hepatocellular carcinoma (HCC).